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1. Introduction 
With the realisation that gangliosides are probably 
present in most if not all mammalian tissues (cf. [ 1 ] ), 
increasing attention has been paid to their subcellular 
location in extraneural tissues. The available vidence 
indicates that while they are notably enriched in plas- 
ma membrane fractions [2-9], they are also present 
in other intracellular membranes, such as smooth and 
rough endoplasmic reticulum [7,10], Golgi apparatus 
[7] and the membranes ofprimary [11] and second- 
ary [ 12] lysosomes. They may be absent from mito- 
chondria [2]. Several recent reports have described the 
presence of gangliosides and neutral g ycosphingolipids 
(GSLs) in skeletal muscle [13-16]. Several sugar resi- 
dues have been detected subsequent tohydrolysis of 
lipid extracts of the sarcoplasmic reticulum (SR) frac- 
tion of rabbit skeletal muscle [17], indicating the pre- 
sence of glycolipids in this membrane system. Sarzala 
et al. [18] have also provided preliminary evidence of 
the presence of GSLs in this SR fraction. In order to 
extend the available information on the possible dis- 
tribution of gangliosides and neutral GSLs in intracel- 
lular membranes we have investigated their presence 
in the SR fraction of rabbit skeletal muscle, an intra- 
cellular membrane fraction of relatively simple compo- 
sition that can be prepared in high purity [ 19]. 
2. Materials and methods 
Albino rabbits weighing 3-3.5 kg were killed by 
cervical dislocation and decapitation. White muscle from 
the dorsum and legs totalling about 400 g was removed 
from each rabbit. The procedure of MacLennan [19] 
was used to prepare the SR fraction (R 1 washed frac- 
tion). This preparation is free of mitochondrial ATPase 
and of Na~" + IC ATPase activities. The Ca:+-dependent 
ATPase (R4 fraction) of the SR was prepared by the 
method ofMacLennan et al. [20]. Gangliosides were 
extracted from whole muscle preparations and from 
SR fractions by the method of Suzuki [21], as pre- 
viously utilized by our laboratory [22]. After a preli- 
minary mild alkaline methanolysis to remove alkali- 
labile lipid contaminants, he lipid-bound sialic acid 
(LBSA) content of the ganglioside fractions was estima- 
ted by the procedure of Svennerholm [23] as modified 
by Miettinen and Takki-Luukkainen [24]. The lower 
phase of the Folch extract was dried, its weight deter- 
mined and esignated asthe weight of the total lipid 
fraction. The lower phase lipids were also subjected to 
mild alkaline methanolysis and their neutral GSL and 
sulfatide components purified by a modification [25] 
of the procedure of Vance and Sweeley [26]. For fa- 
cilitation of description, sulfatide is subsequently clas- 
sed with the neutral GSLs, as operationally it was ob- 
tained with these compounds. Analysis of the patterns 
of gangliosides and neutral GSLs in the various prepa- 
rations was performed utilizing separations by thin 
layer chromatography (TLC) [22]. The sialic acid con- 
tent of individual gangliosides separated by TLC was 
quantitated by the method of MacMillan and Wherrett 
[27]. For the purpose of partial structural studies 
and/or quantitation, the GM3 ganglioside and monogly- 
cosylceramide species were isolated by preparative TI.;C 
and their sugar composition determined by analyses by 
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Table 1 
A. Ganglioside content of rabbit skeletal muscle and 
the SR fraction 
Sample pg LBSA per pg LBSA per 
mg Protein mg Lipid 
Muscle [7] 0.040 ± 0.002 0.36 ± 0.05 
SR [7] 0.613 ± 0.043 0.84 ± 0.07 
Ca 2+ ATPase [I] 0.320 0.53 
B. Percentage distribution of sialic acid in individual 
gangliosides 
Sample GM s GM 1 GD 1 a nd GD lb GT 
Muscle [2] 46.5 14.5 31.0 8.0 
Sr [2] 47.5 18.0 27.0 7.5 
LBSA, protein and lipid were determined asdescribed in the 
text. The percentage distribution of sialic acid in the individual 
gangliosides was measured by the method of MacMillan and 
Wherrett [27] ; the results are expressed asa percentage of the 
total sialic acid recoyered. The composition of the individual 
gangliosides of rabbit skeletal muscle has previously been re- 
ported by Lassaga et al. [14]. Analysis by GLC of the indivi- 
dual GM a species of total muscle and of the SR fraction revea- 
led them to have identical sugar compositions consisting of 
approximately equimolar amounts of glucose, galactose and 
N-acetylneuraminic acid. Their Fatty acid compositions were 
also similar, both showing a predominance of 16:0 and 18:0 
species (cf. [14]). 
gas-liquid chromatography (GLC) of the trimethylsilyl 
derivatives [26]. Gangliosides, galactosyl.ceramide, 
sulfatide and neutral GSL standards were prepared from 
specimens of human brain and kidney obtained at 
autopsy. The ganglioside nomenclature used is that of 
Svennerholm [28]. Protein determinations were per- 
formed by the method of Lowry et al. [29]. 
ximately 2.3-fold in its ganglioside content as compa- 
red with whole muscle.The percentage distribution 
of sialic acid in the individual gangliosides of whole 
muscle and SR fractions is also presented in this 
table; it is evident hat GM3 was the principal 
ganglioside of both fractions and that the distribu- 
tion of the individual gangliosides in whole muscle 
and in the SR fraction was very similar. Further 
confirmation of this observation is presented in
fig. 1A, a photograph of a separation by TLC of 
the gangliosides of whole muscle and of the SR 
fraction along with a standard extract of human 
brain gangliosides. The principal gangliosides of 
both the whole muscle and SR fraction corresponded 
in migration to GM3, GM1, GDla, GDlb, and GT, 
with GM3 the most prominent. The ganglioside 
content of one preparation of the Ca2÷.dependent 
ATPase of the SR was also determined (table 1). 
The enrichment of LBSA in this preparation was 
similar to that shown by the total SR fraction. 
Analysis by TLC showed that the pattern of gang- 
liosides in this preparation was similar to that ex- 
hibited by the total SR fraction. As shown in fig.lB, 
the major neutral GSL in both the muscle and SR pre- 
parations corresponded in chromatographic migration 
to a standard of monogalactosylceramide. Zones cor- 
responding in migration to diglycosylceramide, sulfa- 
tide and triglycosylceramide were also evident in both 
preparations. Analyses by GLC showed that the mono- 
glycosylceramide species of both muscle and SR con- 
tained mainly galactose (65%), but an appreciable am- 
ount of glucose (35%) was also detected. The enrich- 
ment of monoglycosylceramide in the SR fraction was 
approximately 20-fold that of the whole muscle value 
when expressed relative to protein and 2.5-fold when 
expressed relative to total ipid. 
3. Remits 
Quantitative data on the LBSA contents of the who- 
le muscle and SR preparations are presented in table 1. 
In general; the SR preparations were enriched approxi- 
mately 15-fold over whole muscle in their content of 
LBSA when the data were expressed as pg sialic acid per 
mg protein. However, when the data were expressed 
relative to total lipid, the SR was enriched only appro- 
4. Discussion 
Previous tudies have demonstrated the presence of 
GSLs in rat [13], rabbit [14,16] and human [15] ske- 
letal muscle, with considerable structural analyses on 
individual GSLs having been reported in the two latter 
investigations. The pattern of gangliosides observed by 
us in rabbit muscle (fig. 1A and table 1) agrees with 
that previously reported for this tissue [14] in demon- 
strating that GM3 is the principal ganglioside and also 
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Fig. 1A. Thin layer chromatogram of the gangliosides from rabbit skeletal muscle and a derived SR fraction. Gangliosides of: 1, 
skeletal muscle; 2, SR fraction; 3, human brain. Aliquots of gangliosides corresponding in amount o approximately 20pg of LBSA 
were spotted in each channel. The plate was developed in chloroform:methanol:ammonia:water (60 : 35: 1 : 7, v/v/v[v) and sprayed 
with resoreinol reagent. The ganglioside nomenclature is tkat of Svennerholm [ 28 ], A, GM3; B, GM 1 ; C, GD la; D, GD lb; E, GT. 
Fig. lB. Thin layer chromatogram of the neutral GSLs and sulfatide of rabbit skeletal muscle and a deriVed SR fraction. Neutral 
GSLs of: 4, standard mixture af human brain and kidney; 5, SR fraction; 6, skeletal muscle. Aliquots of GSLs corresponding in 
amount o approximately 1 mg were spotted in each channel. The plate was developed in chloroform: methanol:water (65:25:4, 
v/v/v) and sprayed with ardline-diphenylamine reagent. The compounds indicated by the white dots are contaminants and are nei- 
ther neutral GSLs nor sulfatides. The GSLs characteristically resolved as double bands. F, monoglycosylceramide; G. diglycosylce- 
ramide; H, triglycosylceramide; I, tetraglycosylceramide; S, sulfatide. 
that significant amounts of the more complex ganglio- 
sides are present. The SR fraction showed an almost 
identical pattern of  gangliosides to that exhibited by 
whole muscle (fig. IA), but was moderately enriched 
in its ganglioside content (approximately 2.3-fold) as 
compared with whole muscle (table 1) when the data 
were expressed relative to total lipid content. The 
pattern of  neutral GSLs of the SR fraction was also 
very similar to that obtained from whole muscle (fig. 1B), 
with their enrichment in the SR (as revealed by quanti- 
tative determination of the monoglycosylceramide con- 
tent) being of  the same order as that of  the gangliosides. 
The relatively striking enrichments of  ganglioside and 
neutral GSL content in the SR when expressed relative 
to protein probably reflects the high contribution of  
contractile proteins in muscle to the total protein con- 
tent of muscle. It is apparent that expression of  data 
relative to both protein and lipid content is essential 
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if one is to obtain a realistic picture of the distribut- 
tion. Albarracin et al, [16] have recently demonstrated 
the occurrence of neutral GSI_s and sulfatides in rab- 
bit skeletal muscle, but did not report analyses by TLC. 
The fmding that the principal members of the neutral 
GSL class of both SR and whole muscle were compounds 
corresponding in migration to standards of  mono-, di- 
and triglycosylceramides and classical sulfatide is thus 
of interest. This pattern is similar to that described by 
Svennerholm et al. [15] for human skeletal muscle, al- 
though monoglycosylceramide wasthe principal neu- 
tral GSL observed by us, whereas it was only a minor 
component of human muscle. Svennerholm et al. [ 15] 
attributed the presence of galactosylceramide and sul- 
fatide in human muscle to contamination by periphe- 
ral nerve. We consider it unlikely that the purified SR 
fraction would be contaminated to the same extent as 
whole muscle by peripheral nerve. However, even if the 
galactosylceramide and sulfatide were contaminants de- 
rived from nerve, GMa, monoglucosylceramide andthe 
di- and triglycosylceramide species detected in SR and 
whole muscle would appear to be bona fide constituents 
of muscle, since these compounds are not significant 
components of rabbit peripheral nerve [30]. Moreover, 
since the SR fraction of rabbit muscle is a relatively pure 
subeellular fraction (see Materials and methods), it ap- 
pears reasonable to conclude that at least these latter 
GSLs are integral components of this membrane system. 
The purified Ca~+-dependent ATPase, whose content 
of other major lipid classes has previously been report- 
ed to be identical to that of  the total SR [20,31 ], also 
revealed a ganglioside pattern identical with that of  
the total SR; it will be of interest o determine whet- 
her these GSLs play any role in the activity of this 
lipid-dependent enzyme. 
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